unckeyherb
Footballguy
Yes. The news out of the Philippines seems like the exact kind of anecdotal evidence that NP would be touting as proof of efficacy. That we didn't get an email at 6 am today is...shocking.I am honestly a little shocked.
Yes. The news out of the Philippines seems like the exact kind of anecdotal evidence that NP would be touting as proof of efficacy. That we didn't get an email at 6 am today is...shocking.I am honestly a little shocked.
He loves that kind of ####! He’s talked about his mother in law or aunt or whatever she is on every conference call for 9 months.Yes. The news out of the Philippines seems like the exact kind of anecdotal evidence that NP would be touting as proof of efficacy. That we didn't get an email at 6 am today is...shocking.
Maybe NP got fired over the weekend. Or tied up and put in a closet.I am honestly a little shocked.
This is looking pretty accurate.unckeyherb said:No PR today, kind of surprised. I think it pops a little today at the open then slowly trickles down to even.
Seems like you'd know by now. He must need to keep hammering it home. Maybe NP isn't the problem. You people just need to listen better.He’s talked about his mother in law or aunt or whatever she is on every conference call for 9 months.
I think that the agreement with Biomm Pharma to distribute LL in the event of an EUA is a material event and requires an 8k. No new news here, but full-disclosure I am not that smart.Can someone smarter than me tell me what this is about?
https://ir.stockpr.com/cytodyn/sec-filings-email/content/0001193125-21-113216/d168238d8k.htm
Waiting for a PR to burn the shortsThis may be the longest stretch that I have not seen a CYDY post. Middle of page 2, last post Monday at 2pm. I understand why, but damn.
At some point, they have to give an update on the BLA too. Nader said that they would do that in 1-2 weeks at the last CC.Without constant PR's and with the likelihood of an EUA not even being discussed much anymore, I think this will drift down around .10 per day for the next week.
Nader said that they would do that in 1-2 weeks at the last CC
I'm looking to load up in the low 2's as well. My only concern would be the announcement of the FDA denying the EUA application. I believe they would have to announce this as it is a material event. That could cause a downward spike.Think this is going to drift down closer to 2.25 by the end of the week. At which point I'll buy more.
Call me crazy but still looking for entry at $1.60. Willing to wait a while. It will be tempting in the $2.10 range thoughI'm looking to load up in the low 2's as well. My only concern would be the announcement of the FDA denying the EUA application. I believe they would have to announce this as it is a material event. That could cause a downward spike.
I'm with you. I will hold off on buying until they announce an EUA rejection or NP admits that he only sent a request for information regarding the EUA for CD12 and the FDA told him he needed to proceed with CD16. If the stock is in the 2.25 range, this could cause it to briefly dip into prime purchasing range.Call me crazy but still looking for entry at $1.60. Willing to wait a while. It will be tempting in the $2.10 range though
What differentiated this PR with the news in the link below that came out on Jan 29th?
I think it is just announcing the formal agreement has been executed.What differentiated this PR with the news in the link below that came out on Jan 29th?
https://www.marketwatch.com/press-release/chiral-pharma-corp-to-assist-philippine-physicians-apply-for-compassionate-special-permit-csp-to-access-cytodyns-leronlimab-for-covid-19-patients-as-philippines-fda-reviews-each-application-for-approval-to-sell-leronlimab-for-csp-use-2021-01-29?siteid=bigcharts&dist=bigcharts&tesla=y
Lol new day new pump, bay-beeeeeWhat differentiated this PR with the news in the link below that came out on Jan 29th?
https://www.marketwatch.com/press-release/chiral-pharma-corp-to-assist-philippine-physicians-apply-for-compassionate-special-permit-csp-to-access-cytodyns-leronlimab-for-covid-19-patients-as-philippines-fda-reviews-each-application-for-approval-to-sell-leronlimab-for-csp-use-2021-01-29?siteid=bigcharts&dist=bigcharts&tesla=y
And dropped 2 minutes before the market opened. Getting tricky.Lol new day new pump, bay-beeeee
Yeah, I was picturing Nader clapping in glee saying, “Put it out right before the open so no one has a chance to understand it before the stock trades!!!”And dropped 2 minutes before the market opened. Getting tricky.
Or he knows the drugs a bust/long shot and is doing his best to keep the company alive.Yeah, I was picturing Nader clapping in glee saying, “Put it out right before the open so no one has a chance to understand it before the stock trades!!!”
Another prime example that this clown has no clue what he’s doing. He has to go.
I suspect he knows that any Covid plays are most-likely 3 months out and are dependent on the next trial. We can probably expect to see 1 or 2 of these PR's per week for the next while to try and keep the stock price close to $3.Or he knows the drugs a bust/long shot and is doing his best to keep the company alive.
I bought a bunch at 21 thinking pretty much the exact same. But I’m also bought a fair amount of GME at 252 so I’m pretty much the dumbest MF’er here.I just bought into HGEN at $14.78. They were at $13 before the news that they hit their primary. It seems to me that this should be low risk, with the opportunity of a double up on an EUA.
But I have been wrong plenty of times...
I agree with you. I bought some $17.50 calls out until August, if I don't cash good on them, then this stock sucks. I think I will.I just bought into HGEN at $14.78. They were at $13 before the news that they hit their primary. It seems to me that this should be low risk, with the opportunity of a double up on an EUA.
But I have been wrong plenty of times...
I've never done an option but this makes sense to me. You are controlling 100 shares per contract for ~$400 (I checked yahoo finance for the price) instead of buying the 100 shares for ~$1500. Stock price has to be above $21.50 by Aug for you to make a profit... so basically you are betting they get EUA by then. Do I have all that right?I agree with you. I bought some $17.50 calls out until August, if I don't cash good on them, then this stock sucks. I think I will.
Yet it dropped 5%. While CYDY went up on rehashed news from 3 months ago.Fauci mentioned the HGEN drug in House testimony yesterday. Bottom of page 7. Seems like a big positive to me.
https://docs.house.gov/meetings/VC/VC00/20210415/111426/HHRG-117-VC00-Wstate-FauciMDA-20210415.pdf
We’re all just gambling here. I love the odds on Hgen so I’ll keep adding. Doesn’t mean I can’t lose.Yet it dropped 5%. While CYDY went up on rehashed news from 3 months ago.
If Fauci mentioned it, then I am quite confident an EUA is in the bag. Although with the way things are going, who knows what that means to the stock price. Very strange stock reactions lately.
This would have spurned 5 conference calls for cydyFauci mentioned the HGEN drug in House testimony yesterday. Bottom of page 7. Seems like a big positive to me.
https://docs.house.gov/meetings/VC/VC00/20210415/111426/HHRG-117-VC00-Wstate-FauciMDA-20210415.pdf
Oh yea. Easily. The difference in the two companies is startling.This would have spurned 5 conference calls for cydy
And a run up to $7.00This would have spurned 5 conference calls for cydy
This drug works against the virus and as such, it makes sense that it won't work against variants. CYDY and HGEN have drugs that modulate the body's immune response to the virus and therefore, are ambivalent to the variants.https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-monoclonal-antibody-bamlanivimab
Dunno what it means. The italicized is in the original.
Yep, exactlyI've never done an option but this makes sense to me. You are controlling 100 shares per contract for ~$400 (I checked yahoo finance for the price) instead of buying the 100 shares for ~$1500. Stock price has to be above $21.50 by Aug for you to make a profit... so basically you are betting they get EUA by then. Do I have all that right?
The Shorts look like they have completely left CYDY. It's only being shorted on 5.5% of the float whereas HGEN is closer to 16%.Oh yea. Easily. The difference in the two companies is startling.
Think it was easy to hit HGEN since people know it’s a month or two after the results to get the EUA approval. I’m just guessing there but it makes sense to me. I’m grateful though as I’ve loaded up. If it doesn’t work out, I still love the odds. All I can ask for.The Shorts look like they have completely left CYDY. It's only being shorted on 5.5% of the float whereas HGEN is closer to 16%.
Coincidence that jet sold a bunch at four and bought back lower? I think not. I think the rat among us has been sniffed out as a ShortyThe Shorts look like they have completely left CYDY. It's only being shorted on 5.5% of the float whereas HGEN is closer to 16%.
They sold one vialIs there anything to this Phillipines stuff or is this just the latest in the series of CYDY hype that fails to go anywhere.
Yahoo bored is all spun up about something but I can’t really tell what it is. Maybe Chet knows.Is there anything to this Phillipines stuff or is this just the latest in the series of CYDY hype that fails to go anywhere.